Mount Sinai launches phase 1 US trial of NDV-HXP-S, an Egg-based investigational COVID-19 vaccine, in healthy adults previously immunized against COVID-19
A team of clinical investigators at the Icahn School of Medicine at Mount Sinai has announced the launch of a ...